Incidensen af disse hændelser var imidlertid højere hos patienter der fik etoricoxib sammenlignet med de, som fik naproxen 500 mg, 2 gang daglig.
However, the rate of these events was higher in patients receiving etoricoxib compared with those receiving naproxen 500 mg twice daily.